Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Study to evaluate the proportionality of 3 oral doses of pirlindole in healthy volunteers
2012-003090-26Phase 4Completed
- Sponsor
- Tecnimede Group
- Start
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of pirlindole (3 arms), sponsored by Tecnimede Group. Primary endpoint: Primary pharmacokinetic parameters for pirlindole. Started Mar 2013; status: completed.
02
Drugs
pirlindole
Beyond the preview
Go deeper on 2012-003090-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003090-26.